XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Marketable Securities (Tables)
9 Months Ended
Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Schedule of Amortized Cost and Unrealized Gains, Net of Marketable Securities

The amortized cost and unrealized gains, net of marketable securities as of September 30, 2024 and December 31, 2023, were as follows (in thousands):

 

 

As of September 30, 2024

 

 

As of December 31, 2023

 

Marketable securities:

 

 

 

 

 

 

Amortized cost

 

$

2,301

 

 

$

40,110

 

Unrealized gain

 

 

54

 

 

 

289,947

 

Total fair value

 

$

2,355

 

 

$

330,057

 

Schedule Of Net Gain (Loss) of Marketable Securities and Dividend Income

The Company’s net gains/(losses) on marketable securities and dividend income for the three and nine months ended September 30, 2024 and 2023, were as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Gain/(loss) on marketable securities, net

 

$

79

 

 

$

13,225

 

 

$

(27,613

)

 

$

17,642

 

Dividend income (included in Other income, net
   and Special dividend income)

 

$

-

 

 

$

1,705

 

 

$

1,705

 

 

$

201,044

 

 

The portion of unrealized gains/(losses) on marketable securities for the period that relates to marketable securities still held at the reporting date (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Gain/(loss) on marketable securities, net

 

$

79

 

 

$

13,225

 

 

$

(27,613

)

 

$

17,642

 

Less: Net (gain)/loss recognized related to marketable
   securities sold

 

 

(19

)

 

 

(21

)

 

 

27,652

 

 

 

10,630

 

Unrealized gain related to marketable
   securities still held

 

$

60

 

 

$

13,204

 

 

$

39

 

 

$

28,272